The status of TB vaccine development
TB represents the leading global cause of death from an infectious agent. Controlling the TB epidemic thus represents an urgent global public health priority. Epidemiological modelling suggests that, although drug treatments for TB continue to improve, WHO timelines to control the spread of the disease require a new vaccine capable of preventing TB, particularly in adolescents and adults.
‘The status of tuberculosis vaccine development’ reviews the current status of TB vaccine candidates and outlines the diversified vaccine development that are underway.
To access the full publication, click here.
